<DOC>
	<DOCNO>NCT00499005</DOCNO>
	<brief_summary>Intramuscular carbetocin effective intramuscular syntometrine prevention postpartum haemorrhage</brief_summary>
	<brief_title>Carbetocin Versus Syntometrine Third Stage Labour</brief_title>
	<detailed_description>Postpartum haemorrhage ( PPH ) excessive bleed childbirth potentially life threaten complication one major contributor maternal mortality morbidity worldwide ( Lewis 2001 ) .Among various agent study addition routine oxytocin syntometrine ( adverse effect ) , oxytocin agonist ( carbetocin ) appear promising indication ( Chong 2004 ) . Carbetocin license medication use prevention postpartum haemorrhage Singapore many country . It long-acting synthetic octapeptide analogue oxytocin agonist properties.The clinical pharmacological property carbetocin similar naturally occur oxytocin . Like oxytocin , carbetocin bind oxytocin receptor present smooth musculature uterus , result rhythmic contraction uterus , increased frequency exist contraction , increase uterine tone . In pharmacokinetic study , intravenous injection carbetocin produce tetanic uterine contraction within two minute , last six minute , follow rhythmic contraction hour.Intramuscular injection produce tetanic contraction less two minute , last 11 minute , follow rhythmic contraction additional two hour . The prolonged duration activity intramuscular compare intravenous carbetocin significant ( Hunter 1992 ) . In comparison oxytocin , carbetocin induces prolong uterine response administer postpartum , term amplitude frequency contraction . The potential advantage intramuscular carbetocin intramuscular oxytocin long duration action . Its relative lack gastrointestinal cardiovascular side-effects also prove advantageous compare syntometrine ergot alkaloid .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Carbetocin</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<mesh_term>Syntometrine</mesh_term>
	<criteria>1 . Any pregnant woman expect deliver vaginally 2 . Age 21 marry 3 . Ability provide inform consent 1 . Multiple pregnancy 2 . Patients risk factor postpartum haemorrhage 3 . Patients plan elective caesarean section 4 . History vascular disease coronary artery disease 5 . History hypertension require treatment within last 2 year 6 . History hepatic renal disease 7 . Known suspect coagulopathy 8 . History hypersensitivity oxytocin carbetocin 9 . Any condition use syntometrine/carbetocin contraindicate</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>